You are here: Industry Insights > vaccines

News List

Boosting immunotherapy by targeting cells’ recycling centers fiercebiotech
August 29, 2017
Memory T cells can be boosted with a drug normally used to prevent transplanted organs from being rejected, UCSD researchers found.
GSK opens new aluminium salts facility in Scotland pharmatimes.
August 17, 2017
GlaxoSmithKline has officially opened a new £44 million aluminium salts facility in Montrose, Scotland, which is set to supply ingredients for around 400 million vaccines a year
A vaccine for addiction? Don’t get your hopes up just yet: expert fiercepharma
August 15, 2017
Tom Price says an NIH vaccine for addiction is "an incredibly exciting prospect," but experts say it's far from reality.
Takeda, Biological E ink pact to develop and commercialize vaccines biospectrumasia
June 28, 2017
As per the terms, BE has rights to use Takeda's measles vaccine technology for a combination MR vaccine, pertussis vaccine technology for any pertussis-containing combination vaccine
EU nations urge funding to research new drugs and vaccines for tuberculosis pharmaceutical-technology
May 17, 2017
Leaders representing the French and Netherlands governments have urged for funding to develop new treatment and prevention tools against drug-resistant tuberculosis (TB) at a meeting held in Brussels.
Despite foundering Dengvaxia launch, Sanofi puts up 13.2% vaccines growth in Q1 fiercepharma
May 03, 2017
Sanofi’s vaccines business leaned on strong performances from pediatric, flu and travel shots on the way to 13.2% growth in the first quarter—because it certainly couldn't depend on the foundering dengue vaccine Dengvaxia.
Bexsero gains propel GSK's vaccines unit to pharma-beating 16% growth in Q1 fiercepharma
May 02, 2017
With a new captain at the helm, GlaxoSmithKline maintained its vaccines momentum in the first quarter with 16% growth for the unit, thanks to standout sales from meningitis shots picked up in its Novartis deal.
Bavarian Nordic to produce vaccines with cell line from Valneva fiercepharma
April 19, 2017
Bavarian Nordic has licensed a cell line from Valneva to help it manufacture vaccines based on its modified vaccinia Ankara (MVA) vaccine platform currently used on a smallpox shot and a cancer vaccine.
GSK consolidates DT and TT vax production in Hungary plant, adding 100 jobs fiercepharma
March 14, 2017
With GlaxoSmithKline’s vaccines sales expanding, it figures it needs expanded production as well and some of that will happen at a 10-year-old plant in Hungary as well as Germany.
The end of China’s vaccine scandal? Some Chinese lawyers don’t think so fiercepharma
March 08, 2017
Following up on China's high-profile vaccine scandal, a group of lawyers in the country are calling for more legislation to ensure vaccine safety.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page